Physician profile
Mark Miller
NPI 1699773150
$2,577.36
in general payments reported to CMS, 2019-2025
20 companies · $70.63 in 2025
The $70.63 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $893 · 2021: $126 · 2023: $89.16 · 2025: $70.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $751.80 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $693.48 | 2019-2021 | |
| Gilead Sciences, INC. | $228.77 | 2019-2020 | |
| Janssen Biotech, INC. | $131.74 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.10 | 2019-2020 | |
| Merz North America, INC. | $116.58 | 2019-2021 | |
| Intuitive Surgical, INC. | $89.16 | 2023 | Da Vinci Surgical System |
| Qol Medical, LLC | $80.80 | 2019-2020 | |
| Shire North American Group INC | $60.98 | 2019 | |
| Biotissue Holdings INC. | $49.68 | 2025 | |
| Pfizer INC. | $48.84 | 2020 | |
| Romark Laboratories, Lc | $35.82 | 2020 | |
| Endo Pharmaceuticals INC. | $29.37 | 2019-2020 | |
| Daiichi Sankyo INC. | $29.17 | 2019-2021 | |
| Allergan, INC. | $24.15 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $23.50 | 2020 | |
| Concordia Pharmaceuticals INC. | $21.30 | 2019 | |
| Braintree Laboratories, INC. | $16.74 | 2020 | |
| Ucb, INC. | $14.53 | 2019 | |
| Intercept Pharmaceuticals, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.